Evidence supporting the use of: Medium chain triglycerides (MCT)
For the health condition: Autism

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Medium chain triglycerides (MCTs) have been investigated as a dietary intervention for autism spectrum disorder (ASD), primarily due to their role in ketogenic diets. The scientific rationale centers on the observation that ketogenic diets, which are high in fats (including MCTs) and low in carbohydrates, can alter brain metabolism and neurotransmitter levels. Several small studies and case reports suggest that ketogenic diets might improve some behavioral symptoms in children with ASD, such as social communication and repetitive behaviors. MCT oil is often used in these diets because it is more efficiently converted into ketones than long-chain triglycerides, making it easier to achieve and maintain ketosis.

However, the evidence base is limited. Most research involves small sample sizes, lacks robust controls, or combines MCT with other interventions, making it difficult to isolate the effects of MCTs specifically. While some studies report improvements, others show minimal or no benefit, and potential side effects (such as gastrointestinal upset) must also be considered. Comprehensive, large-scale randomized controlled trials focusing specifically on MCT supplementation in ASD are lacking. Thus, while the use of MCTs has scientific underpinnings and is sometimes employed in clinical practice, the overall strength of evidence supporting its direct benefit for autism is weak to moderate at best. Further research is needed to establish efficacy and safety.

More about medium chain triglycerides (MCT)
More about Autism